Philip Ly (BBMed (Hons)) is a PhD researcher at the Daffodil Centre, a joint venture between the University of Sydney and Cancer Council NSW. He brings experience across clinical trials, evidence synthesis, and both quantitative and qualitative research. For his PhD, Philip is investigating the potential of genomics-informed risk prediction to improve early detection for common cancers in Australia (breast, colorectal, melanoma and prostate). Beyond his PhD, Philip contributes to several projects across the Melanoma and Skin Cancer and Genomics and Precision Health streams at the Daffodil Centre and is actively involved in teaching at the University of Sydney’s School of Public Health. Philip’s broader research interests span cancer epidemiology, cancer prevention and early detection, as well as the application of genetics and genomics in public health. Philip is supported by an Australian Government Research Training Program Scholarship and a University of Sydney Postgraduate Research Scholarship.
